Never attempt to warm the pen artificially using hot water, microwaves, or direct heat sources, as this can degrade the medication
Your doctor will determine the right dose
This is the first published trial to study the impact of a GLP-1 RA in a population with significant CKD, and it supports the renal benefits that had previously been suggested in some of the GLP-1 RA cardiovascular outcome trials
Severity breakdown Of all gastrointestinal adverse events reported in the semaglutide arm: 99.5% were non-serious 98.1% were mild to moderate in severity 4.1% experienced severe GI events (vs
Semaglutide is an excellent option for individuals struggling with weight loss, particularly those with a body mass index (BMI) of 30 or higher, or a BMI of 27 or greater with weight-related health issues such as high blood pressure, diabetes, or high cholesterol